Mass versus personalized medicine against COVID-19 in the “system sciences” era

Laura Teodori; Barbara Osimani; Ciro Isidoro; Seeram Ramakrishna

doi:10.1002/cyto.a.24662

Mass versus personalized medicine against COVID-19 in the “system sciences” era

Laura Teodori, Barbara Osimani, Ciro Isidoro, Seeram Ramakrishna

Dipartimento di Scienze della Salute

Risultato della ricerca: Contributo su rivista › Commento

Abstract

The importance of personalized/precision medicine for targeted therapies and improved outcomes both in terms of efficacy and safety in health care is by now grounded. We here discuss the current landscape of personalized medicine approaches against SARS-CoV-2. A schematic of the approach is illustrated in the figure in the text.

Lingua originale	Inglese
pagine (da-a)	995-999
Numero di pagine	5
Rivista	Cytometry. Part A : the journal of the International Society for Analytical Cytology
Volume	101
Numero di pubblicazione	12
DOI	https://doi.org/10.1002/cyto.a.24662
Stato di pubblicazione	Pubblicato - dic 2022

Accesso al documento

10.1002/cyto.a.24662

Altri file e collegamenti

Link to publication in Scopus

Cita questo

@article{6e13211f259d46ee8a428f0f5d24236c,

title = "Mass versus personalized medicine against COVID-19 in the “system sciences” era",

abstract = "The importance of personalized/precision medicine for targeted therapies and improved outcomes both in terms of efficacy and safety in health care is by now grounded. We here discuss the current landscape of personalized medicine approaches against SARS-CoV-2. A schematic of the approach is illustrated in the figure in the text.",

keywords = "SARS-CoV-2, multi-omics landscape, patient heterogeneity, precision medicine, virus heterogeneity",

author = "Laura Teodori and Barbara Osimani and Ciro Isidoro and Seeram Ramakrishna",

note = "Publisher Copyright: {\textcopyright} 2022 International Society for Advancement of Cytometry.",

year = "2022",

month = dec,

doi = "10.1002/cyto.a.24662",

language = "English",

volume = "101",

pages = "995--999",

journal = "Cytometry. Part A : the journal of the International Society for Analytical Cytology",

issn = "1552-4922",

publisher = "Wiley-Liss Inc.",

number = "12",

}

TY - JOUR

T1 - Mass versus personalized medicine against COVID-19 in the “system sciences” era

AU - Teodori, Laura

AU - Osimani, Barbara

AU - Isidoro, Ciro

AU - Ramakrishna, Seeram

PY - 2022/12

Y1 - 2022/12

N2 - The importance of personalized/precision medicine for targeted therapies and improved outcomes both in terms of efficacy and safety in health care is by now grounded. We here discuss the current landscape of personalized medicine approaches against SARS-CoV-2. A schematic of the approach is illustrated in the figure in the text.

AB - The importance of personalized/precision medicine for targeted therapies and improved outcomes both in terms of efficacy and safety in health care is by now grounded. We here discuss the current landscape of personalized medicine approaches against SARS-CoV-2. A schematic of the approach is illustrated in the figure in the text.

KW - SARS-CoV-2

KW - multi-omics landscape

KW - patient heterogeneity

KW - precision medicine

KW - virus heterogeneity

UR - http://www.scopus.com/inward/record.url?scp=85132121183&partnerID=8YFLogxK

U2 - 10.1002/cyto.a.24662

DO - 10.1002/cyto.a.24662

M3 - Comment/debate

SN - 1552-4922

VL - 101

SP - 995

EP - 999

JO - Cytometry. Part A : the journal of the International Society for Analytical Cytology

JF - Cytometry. Part A : the journal of the International Society for Analytical Cytology

IS - 12

ER -

Mass versus personalized medicine against COVID-19 in the “system sciences” era

Abstract

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo